Terns Pharmaceuticals Inc (TERN)

$TERN 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns’ programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients.

Exchange

NASDAQ

Website

ternspharma.com

$M

Total Revenue

30

Employees

$252M

Market Capitalization

-7.30

Price/Earning ratio

Similar Companies

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Conversion Labs Inc CVLB 108548 35213 3.74 42.66 7.33
Royalty Pharma plc RPRX 18925 2239 2.81 15.20 43.40
Organon & Co. OGN 8905 7891 -4.60 5.10 22.06
Arvinas Inc ARVN 3725 21 7.48 -22.56 -782.93
Tilray Inc TLRY 3241 564 1.08 -8.14 -66.49
ATAI Life Sciences N.V. ATAI 2272 20 4.78 -10.40 -932.88
Cronos Group Inc CRON 2097 57 1.32 -14.52 -258.59
Usana Health Sciences Inc USNA 2079 1254 4.73 14.98 11.09
NRX Pharmaceuticals Inc NRXP 1170 2321 0.45 5.05 9.91
Phathom Pharmaceuticals Inc PHAT 1033 7.01 -6.45 None
Phibro Animal Health Corp. PAHC 893 833 3.70 16.25 6.53
Intersect ENT Inc XENT 893 103 21.65 -13.01 -66.55
Edgewise Therapeutics Inc EWTX 796 2.70 -29.55 None
Fulcrum Therapeutics Inc FULC 711 15 8.62 -9.63 -481.07
Pliant Therapeutics Inc PLRX 614 13 2.51 -7.16 -613.56
Cyteir Therapeutics Inc CYT 596 3.20 -20.62 None
Urovant Sciences Ltd UROV 503 -3.65 -3.08 None
Ikena Oncology Inc IKNA 404 10 2.18 -7.38 -551.28
Chromadex Corp CDXC 394 62 9.92 -16.62 -37.51
Provention Bio Inc PRVB 377 2.53 -2.94 None
Rain Therapeutics Inc RAIN 355 413 2.19 -11.66 123.20
Verrica Pharmaceuticals Inc VRCA 325 12 6.57 -8.92 -301.45
Evolus Inc EOLS 310 77 4.10 -2.08 -171.53
Adicet Bio Inc ACET 280 9 1.22 -4.97 -603.06
Terns Pharmaceuticals Inc TERN 252 1.40 -7.30 None
Milestone Pharmaceuticals Inc MIST 219 15 1.23 -7.37 -215.93
Kaleido Biosciences Inc KLDO 184 1 4.11 -2.07 None
Citius Pharmaceuticals Inc CTXR 179 2.24 -7.81 None
scPharmaceuticals Inc SCPH 167 119 2.45 -5.52 -27.05
Eyenovia Inc EYEN 143 6 16.29 -7.31 -324.94
Aquestive Therapeutics Inc AQST 142 42 -2.95 -2.21 -152.73
LifeMD Inc LFMD 139 64 -22.39 -1.00 -133.55
Eton Pharmaceuticals Inc ETON 124 15 6.13 -10.10 -74.52
Osmotica Pharmaceuticals Plc OSMT 122 190 2.37 -1.31 -47.85
Kala Pharmaceuticals Inc KALA 119 11 1.53 -0.94 None
Xeris Biopharma Holdings Inc XERS 111 34 12.19 -1.44 -248.46
Odonate Therapeutics Inc ODT 110 1.39 -0.94 None
Anebulo Pharmaceuticals Inc ANEB 102 7.93 -2.58 None
Opiant Pharmaceuticals Inc OPNT 100 37 3.03 -96.15 -3.06
Aerpio Pharmaceuticals Inc ARPO 99 15 2.98 -5.24 -28.77
Mannatech Inc MTEX 82 158 3.27 12.89 4.22
Natural Alternatives Internati NAII 80 179 1.07 7.90 6.03
India Globalization Capital In IGC 67 0 2.45 -7.60 -981.18
VYNE Therapeutics Inc VYNE 51 16 0.77 2.31 -554.66
Shineco Inc TYHT 44 3 2.17 -1.55 -159.60
Assertio Holdings Inc ASRT 36 117 0.49 -0.63 -38.05
Dermata Therapeutics Inc DRMA 36 -75.67 -7.32 None
Acasti Pharma Inc ACST 33 0 1.43 -1.66 -611.47
Nabriva Therapeutics Plc NBRV 29 12 0.88 -0.49 -452.55
Lexaria Bioscience Corp LEXX 27 1 3.76 -6.95 -445.15
Bio-Path Holdings Inc BPTH 26 0 1.19 -2.49 18.96
Reviva Pharmaceuticals Holding RVPH 25 1.41 -4.08 None
Baudax Bio Inc BXRX 25 1 -10.80 0.76 9.10
Trevi Therapeutics Inc TRVI 23 1.64 -0.66 None
Timber Pharmaceuticals Inc TMBR 20 0 8.79 0.68 -527.55
Hoth Therapeutics Inc HOTH 19 1.64 -2.02 None
Cyanotech Corp. CYAN 17 34 0.98 13.38 3.83
Sonoma Pharmaceuticals Inc. SNOA 11 17 3.32 -2.16 -31.96

Terns Pharmaceuticals to Present Positive Clinical Data on NASH Programs at AASLD The Liver Meeting® Digital Experience 2021

1d ago, source: Yahoo Finance

Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing ...

Should I Avoid Terns Pharmaceuticals, Inc. (TERN)?

15d ago, source: Yahoo Finance

One of these stocks was Terns Pharmaceuticals, Inc. (NASDAQ:TERN). Is Terns Pharmaceuticals, Inc. (NASDAQ:TERN) an outstanding stock to buy now? Money managers were selling. The number of long ...

Terns Appoints Veteran Biopharmaceutical Executive Ann E. Taylor, M.D. to Board of Directors

21d ago, source: Middle East North Africa Financial Network

(MENAFN- GlobeNewsWire - Nasdaq) FOSTER CITY, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the“Company”) (Nasdaq: TERN ...

Terns Pharmaceuticals to Present at H.C. Wainwright 5th Annual NASH Investor Conference

14d ago, source: Yahoo Finance

FOSTER CITY, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small ...

Sio Gene Therapies Inc.

6d ago, source: Wall Street Journal

1 Day SIOX -1.23% DJIA 1.11% Russell 2K 1.11% Health Care/Life Sciences 0.66% Frank M. Torti Chairman Dermavant Sciences Ltd., Respivant Sciences, Inc., Immunovant, Inc., Aruvant Sciences, Inc ...

Terns Pharmaceuticals to Present Positive Clinical Data on NASH Programs at AASLD The Liver ...

1d ago, source: Associated Press

Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy ...

Terns Pharmaceuticals, Inc. (TERN)

3d ago, source: Yahoo Finance

Stocks rebound after September slump: Dow adds 483 points, or 1.4%, in best start to October since 2003 ...

Terns Appoints Veteran Biopharmaceutical Executive Ann E. Taylor, M.D. to Board of Directors

21d ago, source: Benzinga.com

FOSTER CITY, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage biopharmaceutical ...

Terns Pharmaceuticals Inc Ordinary Shares TERN

5d ago, source: Morningstar%2c Inc.

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...

Terns Appoints Veteran Biopharmaceutical Executive Ann E. Taylor, M.D. to Board of Directors

21d ago, source: MarketWatch

Sept. 28, 2021 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single ...

Terns Pharmaceuticals Inc Ordinary Shares TERN

5d ago, source: Morningstar%2c Inc.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Terns Pharmaceuticals Inc (TERN)

13d ago, source: Investing.com

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and ...

Your Portfolio